Literature DB >> 29162702

Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.

Yoshio Takemoto1,2, Diana P Slough3, Gretchen Meinke4, Christopher Katnik5, Zachary A Graziano3, Bojjibabu Chidipi5, Michelle Reiser5, Mohammed M Alhadidy5, Rafael Ramirez2, Oscar Salvador-Montañés2, Steven Ennis2, Guadalupe Guerrero-Serna2, Marian Haburcak6, Carl Diehl7, Javier Cuevas5, Jose Jalife2,8, Andrew Bohm4, Yu-Shan Lin3, Sami F Noujaim5.   

Abstract

The acetylcholine-activated inward rectifier potassium current ( IKACh) is constitutively active in persistent atrial fibrillation (AF). We tested the hypothesis that the blocking of IKACh with the small molecule chloroquine terminates persistent AF. We used a sheep model of tachypacing-induced, persistent AF, molecular modeling, electrophysiology, and structural biology approaches. The 50% inhibition/inhibitory concentration of IKACh block with chloroquine, measured by patch clamp, was 1 μM. In optical mapping of sheep hearts with persistent AF, 1 μM chloroquine restored sinus rhythm. Molecular modeling suggested that chloroquine blocked the passage of a hydrated potassium ion through the intracellular domain of Kir3.1 (a molecular correlate of IKACh) by interacting with residues D260 and F255, in proximity to I228, Q227, and L299. 1H 15N heteronuclear single-quantum correlation of purified Kir3.1 intracellular domain confirmed the modeling results. F255, I228, Q227, and L299 underwent significant chemical-shift perturbations upon drug binding. We then crystallized and solved a 2.5 Å X-ray structure of Kir3.1 with F255A mutation. Modeling of chloroquine binding to the mutant channel suggested that the drug's binding to the pore becomes off centered, reducing its ability to block a hydrated potassium ion. Patch clamp validated the structural and modeling data, where the F255A and D260A mutations significantly reduced IKACh block by chloroquine. With the use of numerical and structural biology approaches, we elucidated the details of how a small molecule could block an ion channel and exert antiarrhythmic effects. Chloroquine binds the IKACh channel at a site formed by specific amino acids in the ion-permeation pathway, leading to decreased IKACh and the subsequent termination of AF.-Takemoto, Y., Slough, D. P., Meinke, G., Katnik, C., Graziano, Z. A., Chidipi, B., Reiser, M., Alhadidy, M. M., Ramirez, R., Salvador-Montañés, O., Ennis, S., Guerrero-Serna, G., Haburcak, M., Diehl, C., Cuevas, J., Jalife, J., Bohm, A., Lin,Y.-S., Noujaim, S. F. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.

Entities:  

Keywords:  IKACh; atrial fibrillation; potassium inward rectifier

Mesh:

Substances:

Year:  2018        PMID: 29162702      PMCID: PMC5893172          DOI: 10.1096/fj.201700349R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

1.  Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

Authors:  Devleena Shivakumar; Joshua Williams; Yujie Wu; Wolfgang Damm; John Shelley; Woody Sherman
Journal:  J Chem Theory Comput       Date:  2010-04-14       Impact factor: 6.006

2.  Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.

Authors:  Scott Pegan; Christine Arrabit; Wei Zhou; Witek Kwiatkowski; Anthony Collins; Paul A Slesinger; Senyon Choe
Journal:  Nat Neurosci       Date:  2005-02-20       Impact factor: 24.884

Review 3.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

4.  First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation.

Authors:  Steven J Podd; Nicholas Freemantle; Stephen S Furniss; Neil Sulke
Journal:  Europace       Date:  2015-10-12       Impact factor: 5.214

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes.

Authors:  J A Sánchez-Chapula; E Salinas-Stefanon; J Torres-Jácome; D E Benavides-Haro; R A Navarro-Polanco
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Mapping the Gbetagamma-binding sites in GIRK1 and GIRK2 subunits of the G protein-activated K+ channel.

Authors:  Tatiana Ivanina; Ida Rishal; Dalia Varon; Carmen Mullner; Bibiane Frohnwieser-Steinecke; Wolfgang Schreibmayer; Carmen W Dessauer; Nathan Dascal
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

9.  Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation.

Authors:  Niels Voigt; Adina Friedrich; Manja Bock; Erich Wettwer; Torsten Christ; Michael Knaut; Ruth H Strasser; Ursula Ravens; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

Review 10.  An update on atrial fibrillation in 2014: From pathophysiology to treatment.

Authors:  R Ferrari; M Bertini; C Blomstrom-Lundqvist; D Dobrev; P Kirchhof; C Pappone; U Ravens; J Tamargo; L Tavazzi; G G Vicedomini
Journal:  Int J Cardiol       Date:  2015-10-18       Impact factor: 4.164

View more
  9 in total

Review 1.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

2.  Mechanisms by Which Ranolazine Terminates Paroxysmal but Not Persistent Atrial Fibrillation.

Authors:  Rafael J Ramirez; Yoshio Takemoto; Raphaël P Martins; David Filgueiras-Rama; Steven R Ennis; Sergey Mironov; Sandesh Bhushal; Makarand Deo; Sridharan Rajamani; Omer Berenfeld; Luiz Belardinelli; José Jalife; Sandeep V Pandit
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-10-09

3.  The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.

Authors:  Yu Xu; Lucas Cantwell; Andrei I Molosh; Leigh D Plant; Dimitris Gazgalis; Stephanie D Fitz; Erik T Dustrude; Yuchen Yang; Takeharu Kawano; Sumanta Garai; Sami F Noujaim; Anantha Shekhar; Diomedes E Logothetis; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

Review 4.  Cardiac effects and toxicity of chloroquine: a short update.

Authors:  Kanigula Mubagwa
Journal:  Int J Antimicrob Agents       Date:  2020-06-19       Impact factor: 5.283

5.  Protective mechanism of SIRT1 on Hcy-induced atrial fibrosis mediated by TRPC3.

Authors:  Lu Han; Yanhua Tang; Shaochuan Li; Yanqing Wu; Xiaoshu Chen; Qinghua Wu; Kui Hong; Juxiang Li
Journal:  J Cell Mol Med       Date:  2019-11-04       Impact factor: 5.310

Review 6.  Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis.

Authors:  Louise Reilly; Lee L Eckhardt
Journal:  Heart Rhythm       Date:  2021-04-20       Impact factor: 6.343

7.  The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation.

Authors:  Catalina Tobón; Laura C Palacio; Bojjibabu Chidipi; Diana P Slough; Thanh Tran; Nhi Tran; Michelle Reiser; Yu-Shan Lin; Bengt Herweg; Dany Sayad; Javier Saiz; Sami Noujaim
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810

Review 8.  Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Pim R R van Gorp; Serge A Trines; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Front Cardiovasc Med       Date:  2020-03-31

9.  Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis.

Authors:  Kun Zuo; Xiandong Yin; Kuibao Li; Jing Zhang; Pan Wang; Jie Jiao; Zheng Liu; Xiaoqing Liu; Jiapeng Liu; Jing Li; Xinchun Yang
Journal:  mSphere       Date:  2020-03-18       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.